Safety and efficacy of the FilterWire EZ in acute ST-segment elevation myocardial infarction

Victor Guetta1, Morris Mosseri, Michael Shechter

  • 1Chaim Sheba Medical Center, Tel Hashomer, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. guettav@netvision.net.il

Insights

Using an embolic protection device during percutaneous coronary intervention for ST-segment elevation myocardial infarction did not improve reperfusion outcomes. The FilterWire EZ showed no significant benefit over conventional PCI in this patient group.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) aims for optimal reperfusion.
  • Distal embolization of atherothrombotic particles can limit myocardial reperfusion despite successful epicardial reperfusion.
  • Embolic protection devices are designed to capture debris during PCI.

Purpose of the Study:

  • To assess if capturing embolic particles during PCI improves myocardial reperfusion in STEMI patients.
  • To compare the efficacy of FilterWire EZ versus conventional PCI in achieving reperfusion markers.

Main Methods:

  • A multicenter, prospective, randomized controlled study involving 100 STEMI patients.
  • Patients were randomized to PCI with FilterWire EZ (n=51) or conventional PCI (n=49).
  • Efficacy endpoints included Thrombolysis In Myocardial Infarction (TIMI) grade flow, myocardial blush score, and ST-segment elevation resolution.

Main Results:

  • The FilterWire EZ was successfully deployed in 84% of cases.
  • No significant differences were observed in epicardial or myocardial reperfusion markers between groups.
  • Subgroup analysis suggested potential benefit in larger vessels (>2.5 mm diameter) for myocardial blush score.

Conclusions:

  • Adjunctive use of FilterWire EZ did not improve angiographic or electrocardiographic measures of reperfusion in STEMI patients compared to conventional PCI.
  • The device showed no overall advantage in improving myocardial reperfusion outcomes.
  • Further research may be warranted for specific patient subgroups or device modifications.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...